Viewing Study NCT05672251


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2025-12-25 @ 9:34 PM
Study NCT ID: NCT05672251
Status: RECRUITING
Last Update Posted: 2025-10-06
First Post: 2023-01-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor: City of Hope Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module